211 related articles for article (PubMed ID: 36990096)
1. An immunometabolism subtyping system identifies S100A9
Bao X; Wang D; Dai X; Liu C; Zhang H; Jin Y; Tong Z; Li B; Tong C; Xin S; Li X; Wang Y; Liu L; Zhu X; Fu Q; Zheng Y; Deng J; Tian W; Guo T; Zhao P; Chen W; Fang W
Cell Rep Med; 2023 Apr; 4(4):100987. PubMed ID: 36990096
[TBL] [Abstract][Full Text] [Related]
2. A multiomics analysis-assisted deep learning model identifies a macrophage-oriented module as a potential therapeutic target in colorectal cancer.
Bao X; Li Q; Chen D; Dai X; Liu C; Tian W; Zhang H; Jin Y; Wang Y; Cheng J; Lai C; Ye C; Xin S; Li X; Su G; Ding Y; Xiong Y; Xie J; Tano V; Wang Y; Fu W; Deng S; Fang W; Sheng J; Ruan J; Zhao P
Cell Rep Med; 2024 Feb; 5(2):101399. PubMed ID: 38307032
[TBL] [Abstract][Full Text] [Related]
3. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma.
Wang Y; Zheng XD; Zhu GQ; Li N; Zhou CW; Yang C; Zeng MS
Front Immunol; 2022; 13():861328. PubMed ID: 35479084
[TBL] [Abstract][Full Text] [Related]
5. Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer.
Kim M; Min YK; Jang J; Park H; Lee S; Lee CH
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34253638
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment-associated gene C3 can predict the prognosis of colorectal adenocarcinoma: a study based on TCGA.
Liu Y; Wang X
Clin Transl Oncol; 2021 Sep; 23(9):1923-1933. PubMed ID: 33765255
[TBL] [Abstract][Full Text] [Related]
7. Multiomics characterization of pyroptosis in the tumor microenvironment and therapeutic relevance in metastatic melanoma.
Chen W; He Y; Zhou G; Chen X; Ye Y; Zhang G; Liu H
BMC Med; 2024 Jan; 22(1):24. PubMed ID: 38229080
[TBL] [Abstract][Full Text] [Related]
8. Immune landscape of distinct subtypes in urothelial carcinoma based on immune gene profile.
Peng M
Front Immunol; 2022; 13():970885. PubMed ID: 36003383
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
10. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy.
Liu Y; Xun Z; Ma K; Liang S; Li X; Zhou S; Sun L; Liu Y; Du Y; Guo X; Cui T; Zhou H; Wang J; Yin D; Song R; Zhang S; Cai W; Meng F; Guo H; Zhang B; Yang D; Bao R; Hu Q; Wang J; Ye Y; Liu L
J Hepatol; 2023 Apr; 78(4):770-782. PubMed ID: 36708811
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis.
Wu X; Yan H; Qiu M; Qu X; Wang J; Xu S; Zheng Y; Ge M; Yan L; Liang L
Elife; 2023 Jun; 12():. PubMed ID: 37267125
[TBL] [Abstract][Full Text] [Related]
12. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
13. Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer.
Luo W; Xiang W; Gan L; Che J; Li J; Wang Y; Han L; Gu R; Ye L; Wang R; Zhang X; Xu Y; Dai W; Mo S; Li Q; Cai G
J Transl Med; 2022 May; 20(1):235. PubMed ID: 35590418
[TBL] [Abstract][Full Text] [Related]
14. Classification of colorectal carcinoma subtypes based on ferroptosis-associated molecular markers.
Yue Q; Zhang Y; Wang F; Cao F; Duan X; Bai J
World J Surg Oncol; 2022 Apr; 20(1):117. PubMed ID: 35410338
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis revealed that distinct cuprotosis patterns reshaped tumor microenvironment and responses to immunotherapy of colorectal cancer.
Xu X; Ding C; Zhong H; Qin W; Shu D; Yu M; Abuduaini N; Zhang S; Yang X; Feng B
Front Immunol; 2023; 14():1165101. PubMed ID: 37006250
[TBL] [Abstract][Full Text] [Related]
16. Single-cell dissection reveals the role of DNA damage response patterns in tumor microenvironment components contributing to colorectal cancer progression and immunotherapy.
Shen X; Mo S; Wang Y; Lin L; Liu Y; Weng M; Gu W; Nakajima T
Genes Cells; 2023 May; 28(5):348-363. PubMed ID: 36811212
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment.
Zheng X; Ma Y; Bai Y; Huang T; Lv X; Deng J; Wang Z; Lian W; Tong Y; Zhang X; Yue M; Zhang Y; Li L; Peng M
Front Immunol; 2022; 13():984480. PubMed ID: 36389763
[TBL] [Abstract][Full Text] [Related]
18. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
[TBL] [Abstract][Full Text] [Related]
19. Unraveling Colorectal Cancer and Pan-cancer Immune Heterogeneity and Synthetic Therapy Response Using Cuproptosis and Hypoxia Regulators by Multi-omic Analysis and Experimental Validation.
Jiang PC; Fan J; Zhang CD; Bai MH; Sun QQ; Chen QP; Mao W; Tang BF; Lan HY; Zhou YY; Zhu J
Int J Biol Sci; 2023; 19(11):3526-3543. PubMed ID: 37496994
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy.
Cheruku S; Rao V; Pandey R; Rao Chamallamudi M; Velayutham R; Kumar N
Int Immunopharmacol; 2023 Mar; 116():109569. PubMed ID: 36773572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
